MANGALAM2023-04-012023-06-30 MANGALAM2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member MANGALAM2023-06-30 MANGALAM2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532637 MANGALAM NOTLISTED Mangalam Drugs And Organics Limited Equity 2023-04-01 2024-03-31 2023-08-10 2023-08-03 INR Lakhs First quarter 16:00:00 17:30:00 2023-08-10 2023-08-10 Not applicable Single segment Manufacturing of Bulk Drugs 2023-04-01 2023-06-30 Unaudited Standalone 874680000.00 196000.00 874876000.00 596620000.00 24000.00 62072000.00 88853000.00 34119000.00 34186000.00 161856000.00 977730000.00 -102854000.00 0.00 -102854000.00 0.00 -7500000.00 -7500000.00 0.00 -95354000.00 0.00 0.00 0.00 0.00 -95354000.00 312000.00 -95042000.00 0.00 0.00 1582824800000.00 10 -6.02 -6.02 0.00 0.00 -6.02 -6.02 The above results have been prepared in accordance with Indian Accounting Standard (Ind AS) notified under section 133 of the companies Act  2013, read together with Companies (Indian Accounting Standard) Rules, 2015 and relevant amendments rules thereafter. The above unaudited financial results have been reviewed by the Audit Committee and thereafter, were approved & taken on record by the Board of Directors of the Company at their meeting held on August 10, 2023. The Statutory Auditors have completed limited review report As the Company's business activity falls within a single primary Business Segment Viz. “Manufacturing of Bulk Drugs” and hence does not have any additional disclosure to be made under Ind AS-108 on “Operating Segments”. The figures of the quarter ended March 31, 2023 are the balancing figures between audited figures in respect of full financial year upto March 31, 2023 and the unaudited published year-to-date figures upto December 31, 2022 being the date of the end of the third quarter of financial year respectively which were subjected to limited review. Figures for the previous periods have been regrouped / re-classified to conform with the figures of the current period. Other Expenses 161856000.00 Other comprehensive income [Abstract] 312000.00 312000.00 0.00 0.00